EMA — authorised 13 July 2011
- Marketing authorisation holder: Glaxo Group Ltd.
- Status: approved
🇪🇺 Lymphostat B in European Union
EMA authorised Lymphostat B on 13 July 2011
Marketing authorisation
Lymphostat B in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lymphostat B approved in European Union?
Yes. EMA authorised it on 13 July 2011.
Who is the marketing authorisation holder for Lymphostat B in European Union?
Glaxo Group Ltd. holds the EU marketing authorisation.